HIV – Bianca Nogrady

‘When prevention disappears, infections rise’: can the world still end AIDS?

October 22, 2026No Comments

From Nature, 7 October 2026: The year 2016 was one for the history books. It saw Donald Trump winning the US presidential election, the United Kingdom voting to leave the European Union and the declaration of Zika virus — a mosquito-borne and sexually transmitted virus that causes severe birth defects — as a global public-health … Continue reading ‘When prevention disappears, infections rise’: can the world still end AIDS?

Australia reaches a major milestone in the effort to end AIDS

September 22, 2026No Comments

From The Saturday Paper, 19 September 2026: On June 5, 1981, the United States Centers for Disease Control issued a report on five young men diagnosed with severe pneumonia caused by a yeast-like fungus then called Pneumocystis carinii. The cases were noteworthy because this infection only affected people with severely compromised immune systems. These young … Continue reading Australia reaches a major milestone in the effort to end AIDS

Will miracle HIV drug go on the PBS?

July 11, 2025No Comments

From The Saturday Paper, 5 July 2025: Standing ovations are rare at scientific conferences. Infectious diseases physician Professor Sharon Lewin, director of the Peter Doherty Institute for Infection and Immunity in Melbourne, still gets “tingly” at the memory of about 10,000 attendees surging to their feet at the 25th International AIDS Conference in Munich a … Continue reading Will miracle HIV drug go on the PBS?

Daily statin cuts cardiovascular risk in HIV

August 1, 2023No Comments

From Medscape Medical News, 24 July 2023 Statins should be considered for primary prevention in people living with HIV who are at low-to-moderate risk of cardiovascular disease, according to final data from the REPRIEVE trial that show pitavastatin therapy is associated with a significantly lower risk of cardiovascular events than placebo. “There was a significant 35% lower … Continue reading Daily statin cuts cardiovascular risk in HIV

Sixth child dies from congenital syphilis in northern Australia

March 20, 2018No Comments

From the BMJ.com, 20 March 2018: Australia has recorded its sixth infant death from congenital syphilis, in a seven year long epidemic that has disproportionately impacted remote Aboriginal communities. The outbreak began in January 2011 in northwest Queensland, and over the following two years spread across to the Northern Territory, then to Western Australia, and … Continue reading Sixth child dies from congenital syphilis in northern Australia

Interferon-free HCV-1 regimen scored high in patients co-infected with HIV

July 27, 2014No Comments

From Internal Medicine News, 24 July 2014: MELBOURNE – A regimen of ABT-450 coformulated with ritonavir, ombitasvir, and dasabuvir, plus ribavirin, resulted in high rates of sustained virologic response in hepatitis C patients co-infected with HIV. Further, the treatment approach did not have a negative effect on HIV viral load. Data from the open-label study, … Continue reading Interferon-free HCV-1 regimen scored high in patients co-infected with HIV

Tuberculosis, malaria, and HIV in decline since Millennium Declaration

July 27, 2014No Comments

From Skin and Allergy News, 21 July 2014: Tuberculosis, HIV, and malaria incidence and mortality have all declined significantly since the formulation of Millennium Development Goal 6 in 2000, which focused global attention on these three diseases and made them a priority. Analysis of data from the Global Burden of Disease Study 2013 showed that … Continue reading Tuberculosis, malaria, and HIV in decline since Millennium Declaration

Sofosbuvir achieves sustained response in patients with hepatitis C and HIV

July 27, 2014No Comments

From Skin and Allergy News, 21 July 2014: Treatment with the interferon-free oral nucleotide analog sofosbuvir plus ribavirin achieved high rates of sustained virologic response in patients with HIV coinfected with hepatitis C, according to data from an open-label phase III study. Researchers observed an 82% response rate among treatment-naive patients coinfected with hepatitis C … Continue reading Sofosbuvir achieves sustained response in patients with hepatitis C and HIV

Stem cell transplantation achieved temporary HIV remission

July 22, 2014No Comments

From Family Practice News, 21 July 2014: Allogeneic hematopoietic stem cell transplantation from HIV-naive individuals to HIV-1–positive individuals may achieve temporary antiretroviral-free remission of infection and loss of detectable HIV-1, a study showed. Two men with chronic HIV-1 infection received allogeneic hematopoietic stem cell transplants (HSCTs) from susceptible donors to treat Hodgkin’s and non-Hodgkin’s lymphoma, … Continue reading Stem cell transplantation achieved temporary HIV remission

International AIDS conference pays tribute to colleagues on flight MH17

July 22, 2014No Comments

From Family Practice News, 21 July 2014: MELBOURNE – Speakers at the opening plenary of the 20th International AIDS Conference struggled with their emotions as they paid tribute to colleagues – including former International AIDS Society President Dr. Joep Lange – who were killed when Malaysian Airlines flight MH17 crashed in Ukraine. Dr. Lange was … Continue reading International AIDS conference pays tribute to colleagues on flight MH17